Literature DB >> 15509540

Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease.

Tatyana V Masyuk1, Bing Q Huang, Anatoliy I Masyuk, Erik L Ritman, Vicente E Torres, Xiaofang Wang, Peter C Harris, Nicholas F Larusso.   

Abstract

Hepatic polycystic disease occurs alone or in combination with polycystic kidney disease (PKD). In autosomal recessive PKD (ARPKD), liver lesions are the major cause of morbidity and mortality in older patients. ARPKD is caused by a mutation to PKHD1 and the PCK rat is an orthologous model of disease. Recently, we showed that fibrocystin, Pkhd1 protein, is localized to primary cilia in rat cholangiocytes and that disruption of its ciliary expression results in biliary cystogenesis. This study describes biliary phenotype in the PCK rat using micro-computed tomography scanning and three-dimensional reconstruction, and light, scanning, and transmission microscopy. Our results show that the biliary tree undergoes extensive remodeling resulting in bile duct dilatation, focal budding, and formation of cysts that are initially connected to bile ducts, but throughout time separate from them. Progressive liver enlargement results from massive cyst formation while liver parenchymal volume remains unchanged. Cilia in cystic cells are abnormal consistent with the notion that the primary defect in ARPKD resulting in cystogenesis may be linked to ciliary dysfunction. Our results suggest that the PCK rat is a useful model for studies of biliary cystogenesis and treatment options of inherited cystic liver disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509540      PMCID: PMC1618661          DOI: 10.1016/S0002-9440(10)63427-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Caloric restriction improves thermotolerance and reduces hyperthermia-induced cellular damage in old rats.

Authors:  D M Hall; T D Oberley; P M Moseley; G R Buettner; L W Oberley; R Weindruch; K C Kregel
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

Review 2.  Polycystic kidney disease.

Authors:  Patricia D Wilson
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

3.  The microanatomy of the intrahepatic bile duct in polycystic disease: comparison of the cpk mouse and human.

Authors:  P C Grimm; J F Crocker; D A Malatjalian; M R Ogborn
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

4.  Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated.

Authors:  L M Guay-Woodford; W J Green; J R Lindsey; D R Beier
Journal:  Hum Mol Genet       Date:  2000-03-22       Impact factor: 6.150

5.  Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts.

Authors:  G T Everson; A Scherzinger; N Berger-Leff; J Reichen; D Lezotte; M Manco-Johnson; P Gabow
Journal:  Hepatology       Date:  1988 Nov-Dec       Impact factor: 17.425

6.  The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area.

Authors:  Shixuan Wang; Ying Luo; Patricia D Wilson; George B Witman; Jing Zhou
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

7.  Polycystic liver disease: a study of cyst fluid constituents.

Authors:  M Patterson; J C Gonzalez-Vitale; C J Fagan
Journal:  Hepatology       Date:  1982 Jul-Aug       Impact factor: 17.425

Review 8.  Murine models of polycystic kidney disease: molecular and therapeutic insights.

Authors:  Lisa M Guay-Woodford
Journal:  Am J Physiol Renal Physiol       Date:  2003-12

9.  A genetically determined murine model of infantile polycystic kidney disease.

Authors:  J L Fry; W E Koch; J C Jennette; E McFarland; F A Fried; J Mandell
Journal:  J Urol       Date:  1985-10       Impact factor: 7.450

10.  PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells.

Authors:  Ming-Zhi Zhang; Weiyi Mai; Cunxi Li; Sae-youll Cho; Chuanming Hao; Gilbert Moeckel; Runxiang Zhao; Ingyu Kim; Jikui Wang; Huaqi Xiong; Hong Wang; Yasunori Sato; Yizhong Wu; Yasuni Nakanuma; Marusia Lilova; York Pei; Raymond C Harris; Song Li; Robert J Coffey; Le Sun; Dianqing Wu; Xing-Zhen Chen; Matthew D Breyer; Zhizhuang Joe Zhao; James A McKanna; Guanqing Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  53 in total

1.  Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia.

Authors:  Anatoliy I Masyuk; Bing Q Huang; Christopher J Ward; Sergio A Gradilone; Jesus M Banales; Tatyana V Masyuk; Brynn Radtke; Patrick L Splinter; Nicholas F LaRusso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-15       Impact factor: 4.052

2.  Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease.

Authors:  James J Beaudoin; Jacqueline Bezençon; Yanguang Cao; Katsuhiko Mizuno; Sharin E Roth; William J Brock; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2018-11-30       Impact factor: 3.922

Review 3.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.

Authors:  Rory J Olson; Katharina Hopp; Harrison Wells; Jessica M Smith; Jessica Furtado; Megan M Constans; Diana L Escobar; Aron M Geurts; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2019-08-19       Impact factor: 10.121

Review 5.  Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential.

Authors:  Robert J Kolb; Surya M Nauli
Journal:  Front Biosci       Date:  2008-05-01

6.  Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.

Authors:  Patricia Munoz-Garrido; José J G Marin; María J Perugorria; Aura D Urribarri; Oihane Erice; Elena Sáez; Miriam Úriz; Sarai Sarvide; Ainhoa Portu; Axel R Concepcion; Marta R Romero; María J Monte; Álvaro Santos-Laso; Elizabeth Hijona; Raúl Jimenez-Agüero; Marco Marzioni; Ulrich Beuers; Tatyana V Masyuk; Nicholas F LaRusso; Jesús Prieto; Luis Bujanda; Joost P H Drenth; Jesús M Banales
Journal:  J Hepatol       Date:  2015-06-01       Impact factor: 25.083

7.  Centrosomal abnormalities characterize human and rodent cystic cholangiocytes and are associated with Cdc25A overexpression.

Authors:  Tatyana V Masyuk; Seung-Ok Lee; Brynn N Radtke; Angela J Stroope; Bing Huang; Jesús M Banales; Anatoliy I Masyuk; Patrick L Splinter; Sergio A Gradilone; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2013-11-07       Impact factor: 4.307

8.  HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis.

Authors:  Sergio A Gradilone; Stefan Habringer; Tatyana V Masyuk; Brynn N Howard; Anatoliy I Masyuk; Nicholas F Larusso
Journal:  Am J Pathol       Date:  2014-01-13       Impact factor: 4.307

Review 9.  Therapeutic Targets in Polycystic Liver Disease.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

10.  Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.

Authors:  Jesús M Banales; Tatyana V Masyuk; Pamela S Bogert; Bing Q Huang; Sergio A Gradilone; Seung-Ok Lee; Angela J Stroope; Anatoliy I Masyuk; Juan F Medina; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.